# Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

Study · id `cardio:ct-nct04760717` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04760717](<https://clinicaltrials.gov/study/NCT04760717>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04760717

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 160 participants.

## Technical summary

Registry record NCT04760717. Randomized; triple masking; primary purpose treatment. Start 2021-03-19 (actual); primary completion 2026-02-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT04760717, source copy `cardio:ctgov-nct04760717-2026-09-04`, retrieved 2026-10-26)
- Started: 2021-03-19 (actual) (ClinicalTrials.gov record NCT04760717, source copy `cardio:ctgov-nct04760717-2026-09-04`, retrieved 2026-10-26)
- Primary completion: 2026-02-02 (actual) (ClinicalTrials.gov record NCT04760717, source copy `cardio:ctgov-nct04760717-2026-09-04`, retrieved 2026-10-26)
- Completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT04760717, source copy `cardio:ctgov-nct04760717-2026-09-04`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04760717, source copy `cardio:ctgov-nct04760717-2026-09-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04760717-2026-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
- Acronym: REDUCE
- Condition: Intracerebral Hemorrhage
- Condition: Ischemic Stroke
- Condition: Spironolactone
- Intervention (Drug): Spironolactone Pill
- Lead sponsor: Yale University
- Lead sponsor class: OTHER
- Collaborator: American Heart Association
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Yale University (`cardio:org-yale-university`)
- Registry lists this organization as a collaborator: American Heart Association (`core:aha`)

## Provenance

Content hash: c6cbf274df7382a86827092da9d0decca59a8849bda123c4bc40b5c13e2a9d16
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
